menu
    • menu

    Company profile for SAB Biotherapeutics

    NEW Drugs in Dev: 4
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Modern medicine struggles to keep pace with the emergence, mutation, and diversity of disease. The body’s natural defense system produces polyclonal antibodies against invaders such as viruses, allergens, bacteria, toxins, and other pathogens. SAB Biotherapeutics has developed a first-of-its-kind therapeutic engine—unleashing the power of the body’s native biological defense system to produce immunotherapies that trul...
    Modern medicine struggles to keep pace with the emergence, mutation, and diversity of disease. The body’s natural defense system produces polyclonal antibodies against invaders such as viruses, allergens, bacteria, toxins, and other pathogens. SAB Biotherapeutics has developed a first-of-its-kind therapeutic engine—unleashing the power of the body’s native biological defense system to produce immunotherapies that truly match and overpower the complexity, diversity, and evolution of human disease.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    SAB BiotherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2301 E 60th St N Sioux Falls, SD 57104 844.268.4239
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://sabbiotherapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BioAsia

    Not Confirmed

    envelop Contact Supplier

    BioAsia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    SAB BIO To Participate In Upcoming Investor Conferences
    SAB BIO To Participate In Upcoming Investor Conferences

    04 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/04/3232088/0/en/SAB-BIO-to-Participate-in-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    04 Feb 2026
    Share Share
    SAB BIO Strengthens Board With New Chair & Director
    SAB BIO Strengthens Board With New Chair & Director

    07 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/07/3214459/0/en/SAB-BIO-Strengthens-Board-of-Directors-with-Appointment-of-New-Chair-and-New-Director.html

    GLOBENEWSWIRE
    07 Jan 2026
    Share Share
    SAB BIO To Present At J.P. Morgan Healthcare Conference
    SAB BIO To Present At J.P. Morgan Healthcare Conference

    06 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/06/3213565/0/en/SAB-BIO-to-Present-at-the-44th-Annual-J-P-Morgan-Healthcare-Conference.html

    GLOBENEWSWIRE
    06 Jan 2026
    Share Share
    First Patient Dosed In SAB Bio's SAFEGUARD Trial For Stage 3 T1D
    First Patient Dosed In SAB Bio's SAFEGUARD Trial For Stage 3 T1D

    18 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/18/3207653/0/en/First-Patient-Dosed-in-SAB-BIO-s-SAFEGUARD-Clinical-Trial-of-SAB-142-for-the-Treatment-of-Stage-3-T1D.html

    GLOBENEWSWIRE
    18 Dec 2025
    Share Share
    SAB BIO Reports Positive Phase 1 Results For SAB-142 In Stage 3
    SAB BIO Reports Positive Phase 1 Results For SAB-142 In Stage 3

    17 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/17/3206921/0/en/SAB-BIO-Announces-Positive-Confirmatory-Clinical-Results-from-the-Phase-1-Study-of-SAB-142-in-Development-for-the-Treatment-of-Stage-3-T1D.html

    GLOBENEWSWIRE
    17 Dec 2025
    Share Share
    SAB Bio Presents SAB-142 Data at Asian Diabetes Conference
    SAB Bio Presents SAB-142 Data at Asian Diabetes Conference

    08 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/08/3201467/0/en/SAB-BIO-to-Present-Data-Showcasing-Progress-in-the-Development-of-SAB-142-at-the-Asian-Conference-on-Innovative-Therapies-for-Diabetes-Management.html

    GLOBENEWSWIRE
    08 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search